Article
Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
The Prostate - 1 Oct 2007
Daugherty Sarah E, Shugart Yin Yao, Platz Elizabeth A, Fallin M Daniele, Isaacs William B, Pfeiffer Ruth M, Welch Robert, Huang Wen-Yi, Reding Douglas, Hayes Richard B
Abstract excerpt
BACKGROUND: Alpha-methylacyl-CoA racemase (AMACR), which prepares branched chain fatty acids to be metabolized for energy and is implicated in the activation of the COX-inhibiting form of ibuprofen, is overexpressed in prostate cancer and its precursor lesions. Significant differences in AMACR allele frequencies have been reported for hereditary prostate cancer (HPC), but the relevance of AMACR in the context of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
